News Roundup [abridged Versions Appear In The Paper Journal]

Data for evaluating drugs is often poor, say experts

BMJ 2005; 330 doi: https://doi.org/10.1136/bmj.330.7498.984-d (Published 28 April 2005) Cite this as: BMJ 2005;330:984

This article has a correction. Please see:

  1. Bob Roehr
  1. Washington DC

    Evidence based medicine is moving from relatively simple questions about a drug's safety and effectivenesss to thornier questions of relative clinical effectiveness and cost effectiveness, international experts agreed at a meeting last week. The experts, from the United States, Canada, the United Kingdom, and Germany, had assembled to discuss these issues with congressional and policy staff in Washington, DC.

    “While there is a lot of data out there, unfortunately it is often very poor,” said Dr Peter Littlejohns, director of the UK's National Institute for Health and Clinical Excellence. …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe